148 related articles for article (PubMed ID: 28912595)
1. Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.
Sakata M; Tani H; Anraku M; Kataoka M; Nagata N; Seki F; Tahara M; Otsuki N; Okamoto K; Takeda M; Mori Y
Sci Rep; 2017 Sep; 7(1):11607. PubMed ID: 28912595
[TBL] [Abstract][Full Text] [Related]
2. Formation of vesicular stomatitis virus pseudotypes bearing surface proteins of hepatitis B virus.
Saha MN; Tanaka A; Jinno-Oue A; Shimizu N; Tamura K; Shinagawa M; Chiba J; Hoshino H
J Virol; 2005 Oct; 79(19):12566-74. PubMed ID: 16160184
[TBL] [Abstract][Full Text] [Related]
3. Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.
Tong W; Yin XX; Lee BJ; Li YG
Acta Virol; 2015 Jun; 59(2):189-93. PubMed ID: 26104337
[TBL] [Abstract][Full Text] [Related]
4. Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus.
Emi N; Friedmann T; Yee JK
J Virol; 1991 Mar; 65(3):1202-7. PubMed ID: 1847450
[TBL] [Abstract][Full Text] [Related]
5. Characterization of pseudotype VSV possessing HCV envelope proteins.
Matsuura Y; Tani H; Suzuki K; Kimura-Someya T; Suzuki R; Aizaki H; Ishii K; Moriishi K; Robison CS; Whitt MA; Miyamura T
Virology; 2001 Aug; 286(2):263-75. PubMed ID: 11485395
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus.
Tani H; Iha K; Shimojima M; Fukushi S; Taniguchi S; Yoshikawa T; Kawaoka Y; Nakasone N; Ninomiya H; Saijo M; Morikawa S
J Virol; 2014 Jul; 88(13):7317-30. PubMed ID: 24741091
[TBL] [Abstract][Full Text] [Related]
7. A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection.
Foley HD; McGettigan JP; Siler CA; Dietzschold B; Schnell MJ
Proc Natl Acad Sci U S A; 2000 Dec; 97(26):14680-5. PubMed ID: 11114165
[TBL] [Abstract][Full Text] [Related]
8. Virus entry is a major determinant of cell tropism of Edmonston and wild-type strains of measles virus as revealed by vesicular stomatitis virus pseudotypes bearing their envelope proteins.
Tatsuo H; Okuma K; Tanaka K; Ono N; Minagawa H; Takade A; Matsuura Y; Yanagi Y
J Virol; 2000 May; 74(9):4139-45. PubMed ID: 10756026
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Glycoprotein-Mediated Entry of Severe Fever with Thrombocytopenia Syndrome Virus.
Tani H; Shimojima M; Fukushi S; Yoshikawa T; Fukuma A; Taniguchi S; Morikawa S; Saijo M
J Virol; 2016 Jun; 90(11):5292-5301. PubMed ID: 26984731
[TBL] [Abstract][Full Text] [Related]
10. Vaccinia-vectored expression of the rubella virus structural proteins and characterization of the E1 and E2 glycosidic linkages.
Sanchez A; Frey TK
Virology; 1991 Aug; 183(2):636-46. PubMed ID: 1853566
[TBL] [Abstract][Full Text] [Related]
11. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
Meyer K; Basu A; Ray R
Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the molecules involved in human T-cell leukaemia virus type 1 entry by a vesicular stomatitis virus pseudotype bearing its envelope glycoproteins.
Okuma K; Matsuura Y; Tatsuo H; Inagaki Y; Nakamura M; Yamamoto N; Yanagi Y
J Gen Virol; 2001 Apr; 82(Pt 4):821-830. PubMed ID: 11257187
[TBL] [Abstract][Full Text] [Related]
13. Both Sphingomyelin and Cholesterol in the Host Cell Membrane Are Essential for Rubella Virus Entry.
Otsuki N; Sakata M; Saito K; Okamoto K; Mori Y; Hanada K; Takeda M
J Virol; 2018 Jan; 92(1):. PubMed ID: 29070689
[TBL] [Abstract][Full Text] [Related]
14. Targeting of a heterodimeric membrane protein complex to the Golgi: rubella virus E2 glycoprotein contains a transmembrane Golgi retention signal.
Hobman TC; Woodward L; Farquhar MG
Mol Biol Cell; 1995 Jan; 6(1):7-20. PubMed ID: 7749196
[TBL] [Abstract][Full Text] [Related]
15. Efficient formation of vesicular stomatitis virus pseudotypes bearing the native forms of hepatitis C virus envelope proteins detected after sonication.
Tamura K; Oue A; Tanaka A; Shimizu N; Takagi H; Kato N; Morikawa A; Hoshino H
Microbes Infect; 2005 Jan; 7(1):29-40. PubMed ID: 15716060
[TBL] [Abstract][Full Text] [Related]
16. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein.
Bartz SR; Vodicka MA
Methods; 1997 Aug; 12(4):337-42. PubMed ID: 9245614
[TBL] [Abstract][Full Text] [Related]
17. Identification of the myelin oligodendrocyte glycoprotein as a cellular receptor for rubella virus.
Cong H; Jiang Y; Tien P
J Virol; 2011 Nov; 85(21):11038-47. PubMed ID: 21880773
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of intracellular viral disassembly and processing probed by Bodipy fluorescence dequenching.
Da Poian AT; Gomes AM; Coelho-Sampaio T
J Virol Methods; 1998 Jan; 70(1):45-58. PubMed ID: 9506812
[TBL] [Abstract][Full Text] [Related]
19. RD114 envelope proteins provide an effective and versatile approach to pseudotype lentiviral vectors.
Bell AJ; Fegen D; Ward M; Bank A
Exp Biol Med (Maywood); 2010 Oct; 235(10):1269-76. PubMed ID: 20876083
[TBL] [Abstract][Full Text] [Related]
20. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K; Forman J; Kräusslich HG; Rose JK
Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
